{"id":"8c2ce210-43fe-4687-95ea-ee7f63ee9a06","companyId":"10d2c172-5ed4-4208-a38d-d39d65e66db2","modelName":"Garmin (Venu / Fenix / Forerunner)","slug":"garmin-watch","description":"Garmin (NASDAQ: GRMN; founded 1989 by Gary Burrell and Min Kao) makes biometric-primary multisport watches such as the Venu 3, Fenix 8, and Forerunner 965 with AI augmentation, recorded in the new biometric form factor. Its devices carry optical heart-rate, blood-oxygen, ECG on select models, and skin-temperature sensors, and layer proprietary analytics including Body Battery, Training Load and Training Readiness, advanced sleep tracking with a Sleep Score and coach, all-day stress, and HRV Status. Its one FDA clearance is the ECG App, cleared via 510(k) K221774 with a decision dated January 12, 2023 and launched on January 24, 2023 on the Venu 2 Plus as Garmin's first FDA-cleared feature for on-demand assessment of signs of atrial fibrillation, later expanded by software to other models. A cap-flag applies because most of Garmin's analytics, including blood oxygen, Body Battery, Training Readiness, stress, and Sleep Score, are wellness features rather than FDA-cleared, with Body Battery in particular a proprietary composite rather than a validated clinical metric, making Garmin lighter on FDA-cleared clinical AI than Apple or Fitbit. Garmin is the purchase-only outlier of the cohort: all core health and training features are free with no required membership, and the newer Garmin Connect+ subscription launched March 27, 2025 at $6.99 a month is optional, adding AI Active Intelligence insights and coaching content without gating existing features, in contrast to subscription-only Whoop and membership-required Oura. Its clinical-validation posture is lighter on cleared clinical AI with strong sensor hardware but proprietary, largely non-peer-validated recovery and training metrics, and the accuracy of Body Battery and Training Readiness and any 2026-model specifics are not verified.","formFactor":"biometric","maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{"notes":[{"label":"FDA clearances","value":"ECG App: FDA 510(k) K221774, decision Jan 12 2023, launched Jan 24 2023 on the Venu 2 Plus (Garmin's first FDA-cleared feature; on-demand 30-sec ECG for signs of AFib). Later expanded by software to epix Pro, Fenix 7 Pro, Venu 3, Fenix 8."},{"label":"CAP-FLAG (most of Garmin's AI is wellness)","value":"Pulse Ox/SpO2, Body Battery, Training Readiness, stress, Sleep Score are WELLNESS features, NOT FDA-cleared. Body Battery in particular is a proprietary composite, not a validated clinical metric. Garmin is lighter on FDA-cleared clinical AI than Apple/Fitbit (one cleared feature: ECG)."},{"label":"Model framing (the purchase-only outlier)","value":"Garmin is fundamentally PURCHASE-ONLY: all core health/training features are free, no required membership. The newer Garmin Connect+ ($6.99/mo or $69.99/yr, launched Mar 27 2025) is OPTIONAL and adds AI 'Active Intelligence' insights + coaching content; it does NOT gate existing features. The outlier vs Whoop (subscription-only) / Oura (required membership)."},{"label":"Verification posture","value":"Boundary: biometric-primary + AI-augmented. Clinical posture: lighter on FDA-cleared clinical AI (one cleared feature); strong SENSOR hardware but recovery/training metrics are proprietary, largely NOT peer-validated as clinical instruments. NOT verified: Body Battery / Training Readiness accuracy (proprietary, no clearance); 2026-model specifics."}],"specs":"Venu 3, Fenix 8, Forerunner 965 (+ epix Pro, tactix). Sensors: Elevate optical HR, Pulse Ox (SpO2), ECG (select models), skin temp. AI/health: Body Battery (energy/recovery proxy), Training Load / Training Readiness / recovery-time, advanced sleep + Sleep Score + sleep coach, all-day stress (HRV), HRV Status, Morning Report. Founded 1989 (NASDAQ: GRMN). PURCHASE-ONLY; optional Garmin Connect+ AI subscription ($6.99/mo, Mar 2025) does NOT gate existing features.","formFactor":"biometric (biometric-primary multisport watch + AI augmentation; ECG cleared, rest wellness)"},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K221774","title":"Garmin ECG App FDA 510(k) K221774 (decision Jan 12 2023)","sourceName":"FDA (accessdata)"},{"url":"https://www.garmin.com/en-US/newsroom/press-release/wellness/garmin-ecg-app/","title":"Garmin ECG App (first FDA-cleared Garmin feature; launched Jan 24 2023 on Venu 2 Plus)","sourceName":"Garmin (newsroom)"},{"url":"https://www.garmin.com/en-US/newsroom/press-release/2025/garmin-connect-plus/","title":"Garmin Connect+ optional AI subscription (Mar 27 2025; $6.99/mo; does NOT gate existing features)","sourceName":"Garmin (newsroom)"}],"aliases":["Garmin Venu 3","Garmin Fenix 8","Garmin Forerunner 965"],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"createdAt":"2026-06-03T22:31:50.097Z","updatedAt":"2026-06-03T22:31:50.097Z","jsonLd":{"@context":"https://schema.org","@type":"Product","@id":"https://registry.deploy.report/models/garmin-watch","url":"https://registry.deploy.report/models/garmin-watch","name":"Garmin (Venu / Fenix / Forerunner)","alternateName":["Garmin Venu 3","Garmin Fenix 8","Garmin Forerunner 965"],"description":"Garmin (NASDAQ: GRMN; founded 1989 by Gary Burrell and Min Kao) makes biometric-primary multisport watches such as the Venu 3, Fenix 8, and Forerunner 965 with AI augmentation, recorded in the new biometric form factor. Its devices carry optical heart-rate, blood-oxygen, ECG on select models, and skin-temperature sensors, and layer proprietary analytics including Body Battery, Training Load and Training Readiness, advanced sleep tracking with a Sleep Score and coach, all-day stress, and HRV Status. Its one FDA clearance is the ECG App, cleared via 510(k) K221774 with a decision dated January 12, 2023 and launched on January 24, 2023 on the Venu 2 Plus as Garmin's first FDA-cleared feature for on-demand assessment of signs of atrial fibrillation, later expanded by software to other models. A cap-flag applies because most of Garmin's analytics, including blood oxygen, Body Battery, Training Readiness, stress, and Sleep Score, are wellness features rather than FDA-cleared, with Body Battery in particular a proprietary composite rather than a validated clinical metric, making Garmin lighter on FDA-cleared clinical AI than Apple or Fitbit. Garmin is the purchase-only outlier of the cohort: all core health and training features are free with no required membership, and the newer Garmin Connect+ subscription launched March 27, 2025 at $6.99 a month is optional, adding AI Active Intelligence insights and coaching content without gating existing features, in contrast to subscription-only Whoop and membership-required Oura. Its clinical-validation posture is lighter on cleared clinical AI with strong sensor hardware but proprietary, largely non-peer-validated recovery and training metrics, and the accuracy of Body Battery and Training Readiness and any 2026-model specifics are not verified.","identifier":"8c2ce210-43fe-4687-95ea-ee7f63ee9a06","category":"biometric","publisher":{"@id":"https://deploy.report/#organization"}}}